anchor: The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.
positive: The regulatory alternatives FDA considered in drafting the proposed rule are also discussed in the analysis.
negative: The analysis does not discuss the regulatory alternatives FDA considered in drafting the proposed rule.